4-83463535-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_139076.3(ABRAXAS1):c.755G>A(p.Arg252Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00126 in 1,611,772 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_139076.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABRAXAS1 | NM_139076.3 | c.755G>A | p.Arg252Gln | missense_variant | 8/9 | ENST00000321945.12 | NP_620775.2 | |
ABRAXAS1 | NM_001345962.2 | c.428G>A | p.Arg143Gln | missense_variant | 7/8 | NP_001332891.1 | ||
ABRAXAS1 | XR_001741334.3 | n.919G>A | non_coding_transcript_exon_variant | 9/9 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000821 AC: 125AN: 152190Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000703 AC: 176AN: 250194Hom.: 1 AF XY: 0.000724 AC XY: 98AN XY: 135290
GnomAD4 exome AF: 0.00130 AC: 1904AN: 1459464Hom.: 3 Cov.: 29 AF XY: 0.00129 AC XY: 939AN XY: 726042
GnomAD4 genome AF: 0.000814 AC: 124AN: 152308Hom.: 0 Cov.: 33 AF XY: 0.000644 AC XY: 48AN XY: 74484
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 13, 2014 | FAM175A has been only recently described in association with cancer predisposition and the risks are not well understood. This variant is denoted FAM175A c.755G>A at the cDNA level, p.Arg252Gln (R252Q) at the protein level, and results in the change of an Arginine to a Glutamine (CGA>CAA). This variant has not, to our knowledge, been published in the literature as pathogenic or benign. FAM175A Arg252Gln has been observed with an allele frequency of up to 0.1% in European Americans in the NHLBI Exome Sequencing Project. This variant is a semi-conservative substitution of a positive polar amino acid for a neutral polar one, altering a position that is highly variable throughout evolution and is located in the potential coiled-coil domain. In silico analyses predict this variant to have a benign effect on protein structure and function. At a molecular level, the impact of this missense variant on protein structure and function is not known and thus we consider this to be a variant of uncertain significance. Furthermore, based on the currently available information, cancer risks associated with this variant, and the FAM175A gene, remain unclear. - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | ABRAXAS1: BP4, BS1 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at